Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus. (Q53443252)
Jump to navigation
Jump to search
scientific article published on 31 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus. |
scientific article published on 31 October 2016 |
Statements
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus. (English)
1 reference
Jiayi Xu
1 reference
Songnian Lin
1 reference
Robert W Myers
1 reference
George Addona
1 reference
Joel P Berger
1 reference
Brian Campbell
1 reference
Hsuan-Shen Chen
1 reference
Zhesheng Chen
1 reference
George J Eiermann
1 reference
Nadine H Elowe
1 reference
Brian T Farrer
1 reference
Wen Feng
1 reference
Qinghong Fu
1 reference
Roman Kats-Kagan
1 reference
Michael Kavana
1 reference
Sunita Malkani
1 reference
Kaushik Mitra
1 reference
Michele J Pachanski
1 reference
Xinchun Tong
1 reference
Maria E Trujillo
1 reference
Libo Xu
1 reference
Bei Zhang
1 reference
Fengqi Zhang
1 reference
Rui Zhang
1 reference
Emma R Parmee
1 reference
31 October 2016
1 reference
27
1 reference
2069-2073
1 reference
9
1 reference
Identifiers
1 reference